Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital adjunctive therapy for partial onset seizures
2010-020871-22Phase 3Completed
- Sponsor
- Roxane Laboratories
- Start
- Dec 2010
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of phenobarbital in Focal Onset Epilepsy (3 arms), sponsored by Roxane Laboratories. Primary endpoint: Primary efficacy endpoint. Started Dec 2010; status: completed.
02
Drugs
phenobarbital
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2010-020871-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020871-22.